Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study

BACKGROUND: Treatment of Hepatitis C virus (HCV) infection has evolved from interferon (IFN)-based treatments to direct-acting antivirals (DAAs). Patients with HCV have an elevated psychiatric morbidity (including substance abuse) and patients with such comorbidity have often been excluded from trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundberg, Isak, Lannergård, Anders, Ramklint, Mia, Cunningham, Janet L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975521/
https://www.ncbi.nlm.nih.gov/pubmed/29843679
http://dx.doi.org/10.1186/s12888-018-1735-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975521/
https://www.ncbi.nlm.nih.gov/pubmed/29843679
http://dx.doi.org/10.1186/s12888-018-1735-6

Ejemplares similares